Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect01:28

Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect

A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship01:23

Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship

Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to Professor William J Waddell's letter concerning my paper entitled 'Long-term feeding effects of stevioside sweetener on some toxicological parameters of growing male rats'.

Journal of applied toxicology : JAT·2011
Same author

Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.

Human & experimental toxicology·2010
Same author

Letter to the editor regarding Bailey article.

Chemical research in toxicology·2009
Same author

Dose-response curves in chemical carcinogenesis.

Nonlinearity in biology, toxicology, medicine·2009
Same author

Thermodynamic basis for expressing dose logarithmically.

Toxicology and applied pharmacology·2008
Same author

Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine.

Archives of toxicology·2005
Same journal

Linalool inhalation‒induced anxiety-like effects occur independently of olfactory input and require cytochrome P450 activity.

The Journal of toxicological sciences·2026
Same journal

Protein homeostasis disruption in cisplatin-induced skeletal muscle atrophy: toxicological insights from experimental studies.

The Journal of toxicological sciences·2026
Same journal

A high-fat/high-sucrose/high-cholesterol diet leads to early indications of metabolic dysfunction-associated steatohepatitis-like lesions in obese diabetic mice.

The Journal of toxicological sciences·2026
Same journal

Sensitivity of respiratory cell lines to unsaturated carbonyl compounds in cigarette smoke is regulated by intracellular glutathione.

The Journal of toxicological sciences·2026
Same journal

Virtual internal exposures of lansoprazole administered to cytochrome P450 2C19 poor metabolizers estimated by simplified physiologically based pharmacokinetic modeling.

The Journal of toxicological sciences·2026
Same journal

A case study of virtual control group verification using historical control data at a single facility.

The Journal of toxicological sciences·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

History of dose response.

William J Waddell1

  • 1Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, KY, USA. bwaddell@louisville.edu

The Journal of Toxicological Sciences
|February 2, 2010
PubMed
Summary
This summary is machine-generated.

The history of dose-response relationships spans three eras, highlighting Paracelsus

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

Related Experiment Videos

Last Updated: Jun 16, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

Area of Science:

  • Toxicology and pharmacology.
  • Environmental health and risk assessment.
  • Chemical safety and regulatory science.

Background:

  • The dose-response curve, or chemical concentration-effect relationship, is fundamental to understanding chemical toxicity.
  • Historical analysis of dose-response curves reveals critical shifts in toxicological understanding and methodology.
  • Key figures like Paracelsus recognized the importance of dose in determining chemical toxicity.

Observation:

  • The history of dose-response analysis can be broadly categorized into three eras: Preclassical, Classical, and Current.
  • The Classical Era (approx. 1900-1965) saw significant advancements in the parameters used for data analysis.
  • The Current Era, beginning in the mid-1970s, is marked by the adoption of the linearized multistage model.

Findings:

  • Paracelsus (1493-1541) is credited as the first to emphasize the critical role of dose in chemical toxicity.
  • A significant error in modern toxicology is the use of a linear scale for dose in the linearized multistage model for DNA-reactive carcinogens.
  • The Classical Era established that dose should be plotted on a logarithmic scale, a principle now often ignored.

Implications:

  • Plotting dose on a linear scale distorts dose-response curves at low doses, hindering accurate risk assessment.
  • Failure to use logarithmic scales for dose can impede the detection of relationships between carcinogen exposure and cancer development.
  • Revisiting and adhering to historical principles of dose-response analysis is crucial for accurate toxicological evaluations.